[Already discussed, but I think this strong signal deserves a separate thread]

Chairman of the board buys shares for 12.5 Million NOK.
CEO buys shares for 2.5 Million NOK.
Member of the board buys shares for 6 Million NOK.
(all buying via controlled companies)

------------------------------------------
NATTO: MANDATORY NOTIFICATION OF TRADE AND DISCLOSURE OF LARGE SHAREHOLDING

KG Investment Company AS (org.nr. 986 357 009) has on June 26th entered into a
binding agreement to sell 2 152 317 shares in NattoPharma ASA (org. nr.
987 774 339) to TG Montgomery AS (org. nr. 988 462 624) at a price of NOK 10,50
per share. After completion of this transaction, which is expected to take place
before the end of July 2018, KG Investment Comp AS no longer hold any shares in
NattoPharma ASA.

On the closing of the above transaction, TG Montgomery AS has entered into
binding agreements to sell 571 429 shares to Pro AS (org. nr. 941 869 424) at a
price of NOK 10,50 per share. Pro AS, an entity controlled by Sjur Thorsheim, a
primary insider in NattoPharma ASA, will after this transaction hold 1 911 889
shares in NattoPharma ASA, equal to 10,55% of the outstanding shares in the
company.

TG Montgomery will further, in the same transaction, sell 190 476 shares at a
price of NOK 10,50 per share to Tsambiko Holding AS (org. nr. 989 058 355) and
190 476 shares at a price of NOK 10,50 per share to Cinco Invest AS (org. nr.
916 886 454). Cinco Invest AS is controlled by Kjetil Ramsøy, CEO and primary
insider in NattoPharma ASA. Mr. Ramsøy control 290 476 shares and 125 100
options in NattoPharma after the completion of this transaction.

After these transactions TG Montgomery AS will own 1 735 122 shares in
NattoPharma ASA, representing 9,57% of the outstanding shares in the company.
Frode Bohan, chairman of the Board of Directors and primary insider in
NattoPharma ASA, will directly and indirectly through Bohan & Co AS (1,033,455
shares), TG Montgomery AS (1,735,122 shares), NxT Capital Ltd (452 852 shares)
and a related party, Patrycja Ratusinska (350,000 shares), control 3 571 429
shares in NattoPharma ASA, representing 19,70% of the outstanding shares. Mr.
Bohan also hold 200 000 options in the company.